If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email email@example.com.
Please tell us what format you need. It will help us if you say what assistive technology you use.
Public Health England reports annually on drug resistance and decreased susceptibility in gonorrhoea in England and Wales and has twice provided data which directly influenced changes in treatment guidelines. The current treatment strategy in the UK (and in other countries) has been to adopt a more aggressive approach of dual therapy with injectable ceftriaxone and oral azithromycin.